Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Pancreatic Cancer
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Pancreatic Ductal Adenocarcinoma (133
)
Pancreatic Adenocarcinoma (81
)
Pancreatic Ductal Adenocarcinoma (133
)
Pancreatic Adenocarcinoma (81
)
›
Associations
(499)
News
Trials
Search handles
@ADesaiMD
@AJacomeMD
@APassaroMD
@Amitmahipal79
@AnaVManana
@ArndtVogel
@BenWestphalen
@BenjaminBesseMD
@Betzabe100
@BijoyTelivala
@BrunoBockorny
@CadranelJ
@CathyEngMD
@ChristianRolfo
@DanChenMDPhD
@DanZhaoMD
@DerekAOReilly
@DrBonillaOnc
@DrChoueiri
@DrEstfan
@DrEzraCohen
@DrGPrakash
@DrJashDatta
@DrMiguelPerales
@DrMirallas
@DrOlaLandgren
@DrR_DUNNE
@DrRanaMcKay
@DrShubhamPant
@DrSteveMartin
@DrSukeshiArora
@DrVijayPatil11
@DrYukselUrun
@Dr_Ivanoncologo
@Dr_JJ_Berenguer
@Dr_RShatsky
@Dr_R_Kurzrock
@DucreuxMichel
@ESchattner
@EileenMOReilly
@ErikaHamilton9
@FAndreMD
@FernandoOnco
@FlavioRochaMD
@FogacciJoao
@FunchainMD
@GABOUALFA
@GIcancerDoc
@GarridoLagunaMD
@HCCvPDAC
@HH_Oncodr
@HKennecke
@HalletJulie
@HenningWillers
@JDekervel
@JavleMilind
@Jbauml
@KReissMD
@KimmieNgMD
@KrishanJethwa
@LAbushahin
@LesinskiLab
@LoebStacy
@LorenzaRimassa
@MLJohnsonMD2
@MLPOncoData
@MPishvaian
@MaenAbdelrahim
@ManniMD1
@MiteshBorad
@NievesM42607618
@NiuSanford
@OncoThor
@ParikhSimul
@PatelOncology
@PatrickHwuMD
@PestanaRC
@PeterHoseinMD
@ProfDMThomas
@RHuneburg
@RachelRiechelm2
@RenoHemonc
@Rndubois
@RyanNipp
@SKamath_MD
@SalemGIOncDoc
@ShaalanBeg
@ShepardDale
@SirohiBhawna
@SprakerMDPhD
@StephenVLiu
@SuyogCancer
@SyedAAhmad5
@TaniguchiMD
@TimothyJBrownMD
@TomFlaigMD
@Transplant_Doc
@UmutDisel
@VivekSubbiah
@VoglNY
@aakonc
@aftimosp
@angelopirozzi3
@anita_turk
@antonyruggeri
@anup_kasi
@aparna1024
@barriere_dr
@bmassutis
@cancerassassin1
@cczielinski
@chulkimMD
@cinthiavgauna
@davidhenrymd
@dawood_findakly
@doctorC369
@doctorpemm
@dr_yakupergun
@drallysonocean
@drenriquegrande
@drgandara
@drjgauthier
@drkomanduri
@elmodir
@fedenichetti
@gabe_a_brooks
@heinrich_kat
@jamecancerdoc
@jgong15
@jimhumd
@jonathanloree
@jpaArmand
@jryckman3
@jsoriamd
@kmody29
@lindamahj
@marklewismd
@mihaela_aldea
@mraphaelmd
@mtmdphd
@n8pennell
@naborala
@pashtoonkasi
@protoninfo
@rachnatshroff
@realbowtiedoc
@rschilsky
@scottrberry
@singhv2003
@tmprowell
@todrashish
@tpjmd
@weldeiry
@zpyeung
Search handles
@ADesaiMD
@AJacomeMD
@APassaroMD
@Amitmahipal79
@AnaVManana
@ArndtVogel
@BenWestphalen
@BenjaminBesseMD
@Betzabe100
@BijoyTelivala
@BrunoBockorny
@CadranelJ
@CathyEngMD
@ChristianRolfo
@DanChenMDPhD
@DanZhaoMD
@DerekAOReilly
@DrBonillaOnc
@DrChoueiri
@DrEstfan
@DrEzraCohen
@DrGPrakash
@DrJashDatta
@DrMiguelPerales
@DrMirallas
@DrOlaLandgren
@DrR_DUNNE
@DrRanaMcKay
@DrShubhamPant
@DrSteveMartin
@DrSukeshiArora
@DrVijayPatil11
@DrYukselUrun
@Dr_Ivanoncologo
@Dr_JJ_Berenguer
@Dr_RShatsky
@Dr_R_Kurzrock
@DucreuxMichel
@ESchattner
@EileenMOReilly
@ErikaHamilton9
@FAndreMD
@FernandoOnco
@FlavioRochaMD
@FogacciJoao
@FunchainMD
@GABOUALFA
@GIcancerDoc
@GarridoLagunaMD
@HCCvPDAC
@HH_Oncodr
@HKennecke
@HalletJulie
@HenningWillers
@JDekervel
@JavleMilind
@Jbauml
@KReissMD
@KimmieNgMD
@KrishanJethwa
@LAbushahin
@LesinskiLab
@LoebStacy
@LorenzaRimassa
@MLJohnsonMD2
@MLPOncoData
@MPishvaian
@MaenAbdelrahim
@ManniMD1
@MiteshBorad
@NievesM42607618
@NiuSanford
@OncoThor
@ParikhSimul
@PatelOncology
@PatrickHwuMD
@PestanaRC
@PeterHoseinMD
@ProfDMThomas
@RHuneburg
@RachelRiechelm2
@RenoHemonc
@Rndubois
@RyanNipp
@SKamath_MD
@SalemGIOncDoc
@ShaalanBeg
@ShepardDale
@SirohiBhawna
@SprakerMDPhD
@StephenVLiu
@SuyogCancer
@SyedAAhmad5
@TaniguchiMD
@TimothyJBrownMD
@TomFlaigMD
@Transplant_Doc
@UmutDisel
@VivekSubbiah
@VoglNY
@aakonc
@aftimosp
@angelopirozzi3
@anita_turk
@antonyruggeri
@anup_kasi
@aparna1024
@barriere_dr
@bmassutis
@cancerassassin1
@cczielinski
@chulkimMD
@cinthiavgauna
@davidhenrymd
@dawood_findakly
@doctorC369
@doctorpemm
@dr_yakupergun
@drallysonocean
@drenriquegrande
@drgandara
@drjgauthier
@drkomanduri
@elmodir
@fedenichetti
@gabe_a_brooks
@heinrich_kat
@jamecancerdoc
@jgong15
@jimhumd
@jonathanloree
@jpaArmand
@jryckman3
@jsoriamd
@kmody29
@lindamahj
@marklewismd
@mihaela_aldea
@mraphaelmd
@mtmdphd
@n8pennell
@naborala
@pashtoonkasi
@protoninfo
@rachnatshroff
@realbowtiedoc
@rschilsky
@scottrberry
@singhv2003
@tmprowell
@todrashish
@tpjmd
@weldeiry
@zpyeung
Filter by
Latest
9ms
Researchers are studying several alterations in pancreatic cancer, among them the BRAF mutation. One type of BRAF mutation may provide a target for treatment in pancreatic cancer patients, explains Dr. Michael Pishvaian @MPishvaian. https://t.co/jSMKge2aYR (@letswinpc)
9 months ago
Clinical
|
BRAF (B-raf proto-oncogene)
|
BRAF mutation
9ms
👀 217 patients with FGFR 1-4 alteration ➡️2 median prior systemic therapies 🚨ORR: 29.5% (Prior Therapy ORR 10%) ➡️Pancreatic cancer: 55.6% ➡️Biliary Tract Cancer: 51.6% ➡️Breast Cancer: 31% …. And many more @OncoAlert @VivekSubbiah @OncBrothers @curecc (@DrShubhamPant)
9 months ago
Clinical
|
FGFR1 (Fibroblast growth factor receptor 1)
9ms
Researchers are studying several alterations in pancreatic cancer, among them the BRAF mutation. One type of BRAF mutation may provide a target for treatment in pancreatic cancer patients, explains Dr. Michael Pishvaian @MPishvaian. https://t.co/jSMKge2aYR #TumorBoardTuesday (@letswinpc)
9 months ago
Clinical
|
BRAF (B-raf proto-oncogene)
|
BRAF mutation
9ms
The @lustgartenfdn recently highlighted #BCCPC collaborator @MPishvaian's work leading a study targeting a BRAF mutation in patients with #PancreaticCancer at @JohnsHopkins Great work Dr. Pishvaian! https://t.co/L9ojMLrRjh (@OHSUpancreatic)
9 months ago
Clinical
|
BRAF (B-raf proto-oncogene)
|
BRAF mutation
9ms
YUP!She updated me on a new trial for my RET mutation just before my pancreatic cancer returned. Stage 4 in liver/lungs.Been following me with regular liquid biopsies & tumor markers.Started the trial.Meds killed the cancer in 30 days!! PM me. (@randyeringler)
9 months ago
Liquid biopsy • Metastases • Biopsy
|
RET (Ret Proto-Oncogene)
|
RET mutation
9ms
Super exciting! Let’s go @break_cancer Let’s move the needle for 🔥🔥#KRAS #PancreaticCancer #CancerResearch Trial is ongoing!! @EileenMOReilly @MSKCancerCenter (@CentralParkWMD)
9 months ago
KRAS (KRAS proto-oncogene GTPase)
9ms
Explorations Unearth New Potential of KRAS Mutations in Pancreatic Cancer https://t.co/G5fIaMjHOe via @onclive (@marciasgreen)
9 months ago
KRAS (KRAS proto-oncogene GTPase)
|
KRAS mutation
9ms
In @CCR_AACR #Researchpaper by @KReissMD & team on reversions in BRCA/PALB2 ✅ #PancreaticCancer #patients treated w PARPi❌ ⚠️ Reversions led to💊resistance & poor outcome. #PrecisionMedicine @OncoAlert 🚨#pancsm 💜 @KenOliveLab @quimmateo @Aiims1742 https://t.co/bAfvFLKonR (@BenWestphalen)
9 months ago
Clinical
|
PALB2 (Partner and localizer of BRCA2) • BRCA (Breast cancer early onset)
9ms
Researchers are studying several alterations in pancreatic cancer, among them the BRAF mutation. One type of BRAF mutation may provide a target for treatment in pancreatic cancer patients, explains Dr. Michael Pishvaian (@MPishvaian). https://t.co/jSMKge2aYR (@letswinpc)
9 months ago
Clinical
|
BRAF (B-raf proto-oncogene)
|
BRAF mutation
9ms
Case report by @BenWestphalen @heinrich_kat et al. discussing a patient with #pancreaticcancer bearing a BRAF fusion, leading to MAPK activation, MLHph and finally MSI with response to #immunotherapy ➡️ https://t.co/7v9D0VuQQo #pancsm #immunoonc (@JCOPO_ASCO)
9 months ago
Clinical
|
BRAF (B-raf proto-oncogene)
|
BRAF fusion
9ms
Perfectly timed mentor-mentee paper in @CCR_AACR from @TimothyJBrownMD & @KReissMD The Clinical Implications of Reversions in Patients with Advanced #PancreaticCancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 After Progression on Rucaparib https://t.co/rzYy2fOk24 (@Aiims1742)
9 months ago
Clinical • Metastases
|
BRCA1 (Breast cancer 1, early onset) • BRCA2 (Breast cancer 2, early onset) • PALB2 (Partner and localizer of BRCA2)
|
Rubraca (rucaparib)
9ms
Register by Aug 16 to get the lowest rates for the AACR Special Conference on Pancreatic Cancer (Sept 27-30, Boston), chaired by Christine A. Iacobuzio-Donahue, Anirban Maitra, Rosalie C. Sears, and Jen Jen Yeh. https://t.co/CmNGJOGJD3 #AACRpan23 @ciacobu @Aiims1742 @SearsRosie (@AACR)
9 months ago
9ms
Register today to join @ESSOnews and SSO on August 18th for an in-depth case-based conversation on Multimodality Management of #PancreaticCancer. Register at https://t.co/LznA34P2LA @HalletJulie @AlexParikhMD @PatricioPolanc0 @e_rangelova @DrJasonWillis (@SocSurgOnc)
9 months ago
9ms
Join us in congratulating @PeterHoseinMD! Dr. Hosein was recently announced as a Pancreatic Cancer Action Network (@PanCAN) Scientific & Medical Advisory Board member. Read more: https://t.co/FQh8EzWQJl (@SylvesterCancer)
9 months ago
9ms
Despite the high prevalence of KRAS mutations in pancreatic cancers, a limited number of cases harbor an actionable point mutation. @EileenMOReilly @MSKCancerCenter #pancsm https://t.co/7uqF6ZMfTU (@OncLive)
9 months ago
Clinical
|
KRAS (KRAS proto-oncogene GTPase)
|
KRAS mutation
9ms
Thank you all! We are eternally grateful for all that you do to educate us! 👏🌞😀 #PancChat #pancreaticcancer (@cltpcalliance)
9 months ago
9ms
Is this only available for bone cancer? What about pancreatic? (@Clodagh)
9 months ago
9ms
In @eLife from @3dorganoid @BrunoBockorny & colleagues A Large-Scale Proteomics Resource of Circulating Extracellular Vesicles for Biomarker Discovery in #PancreaticCancer https://t.co/Sr4WxMHdLx Plasma proteomics of EVs from ~125 patients across neoplastic & benign etiologies (@Aiims1742)
9 months ago
Clinical
9ms
.@unmc's @DrKelseyKlute joined our “Leading Nebraska” podcast to share how clinical trials, early detection and early treatment of pancreatic cancer can improve rates of survival and make a difference for patients and families. Listen here: https://t.co/Yf8Z0TmccV #NUforNE (@u_nebraska)
9 months ago
Clinical
9ms
Join @PanCAN for this month's #PancChat tonight at 7 pm CT! Discuss summer safety for #pancreaticcancer patients w/expert co-hosts. To participate, head to https://t.co/0iXOiSCheN & follow along. 💜 @letswinpc @lustgartenfdn @drallysonocean @ShaalanBeg @Aiims1742 @NirajGusani (@PanCANChicago)
9 months ago
Clinical
9ms
Any advances in pancreatic cancer? Been decades! (@Trowy4)
9 months ago
9ms
Register today to join @ESSOnews and SSO on August 18th for an in-depth case-based conversation on Multimodality Management of #PancreaticCancer. Register at https://t.co/8WZVOhZGqA @HalletJulie @AlexParikhMD @PatricioPolanc0 @e_rangelova @DrJasonWillis (@SocSurgOnc)
9 months ago
9ms
Join @PanCAN for #PancChat 💬 Tuesday, 7/18 at 5pm PT/8pm ET! Discuss #summer safety ⛱️ for #pancreaticcancer patients with expert co-hosts in the field. Follow along the chat right here on Twitter! @letswinpc @lustgartenfdn @drallysonocean @ShaalanBeg @Aiims1742 @NirajGusani (@CraigsCauseCan)
9 months ago
Clinical
9ms
.@drallysonocean discusses the use of glutamine to ease the neuropathy caused by chemotherapy drugs for pancreatic cancer. https://t.co/F6k2XTid7I (@letswinpc)
9 months ago
9ms
Also, I don’t think supportive care docs necessarily know the scope of therapeutic options or outcomes and they are sometimes “brought in” to get pts into hospice. PS3 with stage IV pancreatic cancer is very different than PS3 with untreated EGFR mutant lung cancer. (@Alexmenter)
9 months ago
Clinical • Metastases
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation
10ms
Join the USA's #pancreaticcancer thought leaders for #PancChat 💬 on Tuesday, 7/18 at 8pm ET! The Twitter chat will focus on #summer safety 🌞⚕️for patients with expert co-hosts in the field. @letswinpc @lustgartenfdn @PanCAN @drallysonocean @ShaalanBeg @Aiims1742 @NirajGusani (@cltpcalliance)
10 months ago
Clinical
10ms
Join @ESSOnews and SSO on August 18th for an in-depth case-based conversation on multimodality management of #pancreaticcancer. Register at https://t.co/YMjpjvpEEh @HalletJulie @AlexParikhMD @PatricioPolanc0 @e_rangelova @DrJasonWillis (@SocSurgOnc)
10 months ago
10ms
Walking the halls of MD Anderson as a patient has given our Dr. Michael Frumovitz the opportunity to take a first-hand look at the patient experience from start to finish. Read his story here: https://t.co/gNQIxYMCse @Frumovitz #PancreaticCancer #EndCancer (@MDAndersonNews)
10 months ago
Clinical
10ms
👀 Check out what’s popular this week in #JCOPO: "Tumor Mutational Burden in Real-World Patients With #PancreaticCancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness" ➡️ https://t.co/LmJZsDBwyN @FoundationATCG @Amitmahipal79 #pancsm (@JCOPO_ASCO)
10 months ago
Clinical • Checkpoint inhibition • Real-world evidence • Tumor mutational burden • IO biomarker • Real-world
|
TMB (Tumor Mutational Burden)
10ms
@romleidner Hello sir, Saw your many patients reviews on YouTube. Need to talk regarding stage 4 pancreatic cancer. It would mean a world to me if I could get few minutes of yours on an email regarding the above. Gujarathitarang@gmail.com is my email. If ok please share yours. (@GujarathiTarang)
10 months ago
Clinical • Metastases
10ms
Signet-Ring / Poorly Cohesive adenocarcinoma of pancreas, No CDH1 mutations in this highly aggressive pancreatic cancer variant (unlike gastric signet ring cell cancers). Great images. (@RZitwer)
10 months ago
CDH1 (Cadherin 1)
|
CDH1 mutation
10ms
⬆️ FAKi Boosts Anti-PD1 Immunotherapy in Pancreatic Cancer @DrArsenOsipov @danwpaterson @VerastemOncolog @PanCAN @lustgartenfdn @CpcrMsk @DanaFarber_Hale @jgong15 @CedarsSinai @ASCO #defactinib #pembrolizumab #CXCR4 #PDAC 🔻 https://t.co/OQHKJByl0J (@CrozrX)
10 months ago
CXCR4 (Chemokine (C-X-C motif) receptor 4)
|
Keytruda (pembrolizumab) • defactinib (VS-6063)
10ms
Adherence to Pro-Vegetarian Food Patterns and Risk of Oesophagus, Stomach, and Pancreas Cancers: A Multi Case–Control Study (The PANESOES Study) https://t.co/sBboynSRKv #mdpinutrients via @Nutrients_MDPI https://t.co/7MUqJtZDmr (@Shahin75247020)
10 months ago
Adherence
10ms
Adherence to Pro-Vegetarian Food Patterns and Risk of Oesophagus, Stomach, and Pancreas Cancers: A Multi Case–Control Study (The PANESOES Study) https://t.co/sBboynSRKv #mdpinutrients via @Nutrients_MDPI https://t.co/7MUqJtZDmr (@Shahin75247020)
10 months ago
Adherence
10ms
@knittygirl @MarkNormanNews @Rachael_Hodges @HSJEditor @BBCHughPym @sophieRblake @YMasannat @WRicciardi @amirhannan @teamoncology @PancreaticCanUK @doctor_oxford @IsabelHardman @MFTnhs (@biosciencetoday)
10 months ago
10ms
Register by Aug 16 to get the lowest rates for the AACR Special Conference on Pancreatic Cancer (Sept 27-30, Boston), chaired by Christine A. Iacobuzio-Donahue, Anirban Maitra, Rosalie C. Sears, and Jen Jen Yeh. https://t.co/ESbsIurv9a #AACRpan23 @ciacobu @Aiims1742 @SearsRosie (@AACR)
10 months ago
10ms
Explorations Unearth New Potential of KRAS Mutations in Pancreatic Cancer @EileenMOReilly @MSKCancerCenter #pcsm https://t.co/ROtIRmXNMy (@OncLive)
10 months ago
KRAS (KRAS proto-oncogene GTPase)
|
KRAS mutation
10ms
New in @oncogenejournal from Andy Lowy, @HerveTiriac @Bgarg14 @PatelOncology et al @UCSDCancer #PancreaticCancer induces neural injury that promotes a transcriptomic and functional repair signature by peripheral neuroglia https://t.co/62dPjSQODD Digital spatial profiling of… https://t.co/lJg0wmXDfo (@Aiims1742)
10 months ago
10ms
Submit an abstract by July 13 for the AACR Special Conference on Pancreatic Cancer (Sept 27-30, Boston), chaired by Christine A. Iacobuzio-Donahue, Anirban Maitra, Rosalie C. Sears, and Jen Jen Yeh. https://t.co/EwtVkfYAtF #AACRpan23 @ciacobu @Aiims1742 @SearsRosie @YehlabUNC (@AACR)
10 months ago
10ms
You can learn about @MuzumdarLab research - as well from @rushika_perera @ZCMlab in the “Metabolic Perturbations” session chaired by Rushika at @AACR Special Conference on #PancreaticCancer Abstract Deadline is TOMORROW at noon EDT. https://t.co/eJJdaWHiT1 (@Aiims1742)
10 months ago
10ms
Explorations Unearth New Potential of KRAS Mutations in #PancreaticCancer https://t.co/akQ4eEmIq9 Featuring data from #ASCO23 including an early phase KRAS targeted vaccine data in adjuvant setting from Dr. @EileenMOReilly (@Aiims1742)
10 months ago
Clinical
|
KRAS (KRAS proto-oncogene GTPase)
|
KRAS mutation
10ms
This! So exciting to see these vaccines taking shape in both breast cancer and other disease sites (esp pancreas) #TumorBoardTuesday (@JohnEbbenMDPhD)
10 months ago
Clinical
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login